CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hsu, C. Y.
Right arrow Articles by Hurwitz, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hsu, C. Y.
Right arrow Articles by Hurwitz, D. R.

Cell Growth & Differentiation, Vol 1, Issue 4 191-200, Copyright © 1990 by American Association of Cancer Research


ARTICLES

Generation of recombinant cytoplasmic domain of epidermal growth factor receptor with intrinsic protein tyrosine kinase activity

CY Hsu, M Mohammadi, M Nathan, A Honegger, A Ullrich, J Schlessinger and DR Hurwitz
Rorer Biotechnology, Inc., King of Prussia, Pennsylvania 19406.

We have generated a recombinant baculovirus using the high expression vector pVL941 containing the complementary DNA encoding the intracellular domain of the human epidermal growth factor receptor (EGFR-IC). Upon infection of Spodoptera frugiperda insect cells, protein tyrosine kinase-active EGFR-IC was produced. The expressed protein has a molecular weight of 61,000 and is specifically recognized by antibodies directed against peptides representing different regions of human EGFR-IC. Upon sonication of infected cells, EGFR-IC was detected in both the soluble and insoluble fractions of the cell lysate. About 20-50% of the expressed EGFR-IC was soluble. Metabolic labeling and protein analyses showed that EGFR-IC comprised 7% of newly synthesized proteins in the cytoplasmic lysate and 0.1-0.2% of the total soluble protein. We have used a three-step purification procedure (fast-Q-Sepharose and phenyl-Sepharose column chromatographies and 30% ammonium sulfate precipitation) to purify EGFR-IC to 85% purity with 15-20% recovery from the initial soluble lysate. A yield of 3-4 mg of purified EGFR-IC has been consistently produced from 20 roller bottles with 2-4 x 10(8) infected cells/bottle. The tyrosine kinase activity was retained through purification. The enzyme demonstrated much higher autophosphorylation activity in the presence of Mn2+ than Mg2+. Phosphopeptide mapping revealed the same autophosphorylation sites utilized by EGFR-IC as those identified in wild-type EGFR. EGFR-IC-catalyzed phosphorylation of either a synthetic peptide representing the major autophosphorylation site or angiotensin II showed that the baculovirus-expressed EGFR-IC exhibits similar enzymatic kinetic characteristics to the intact activated EGFR kinase.


This article has been cited by other articles:


Home page
J Biol ChemHome page
B. Metge, S. Ofori-Acquah, T. Stevens, and R. Balczon
Stat3 Activity Is Required for Centrosome Duplication in Chinese Hamster Ovary Cells
J. Biol. Chem., October 1, 2004; 279(40): 41801 - 41806.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
E. A. Miljan, E. J. Meuillet, B. Mania-Farnell, D. George, H. Yamamoto, H.-G. Simon, and E. G. Bremer
Interaction of the Extracellular Domain of the Epidermal Growth Factor Receptor with Gangliosides
J. Biol. Chem., March 22, 2002; 277(12): 10108 - 10113.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
P. S. Brignola, K. Lackey, S. H. Kadwell, C. Hoffman, E. Horne, H. L. Carter, J. D. Stuart, K. Blackburn, M. B. Moyer, K. J. Alligood, et al.
Comparison of the Biochemical and Kinetic Properties of the Type 1 Receptor Tyrosine Kinase Intracellular Domains: DEMONSTRATION OF DIFFERENTIAL SENSITIVITY TO KINASE INHIBITORS
J. Biol. Chem., January 11, 2002; 277(2): 1576 - 1585.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
N. Ito, C. Wernstedt, U. Engstrom, and L. Claesson-Welsh
Identification of Vascular Endothelial Growth Factor Receptor-1 Tyrosine Phosphorylation Sites and Binding of SH2 Domain-containing Molecules
J. Biol. Chem., September 4, 1998; 273(36): 23410 - 23418.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
P. Goldschmidt-Clermont, J. Kim, L. Machesky, S. Rhee, and T. Pollard
Regulation of phospholipase C-gamma 1 by profilin and tyrosine phosphorylation
Science, March 8, 1991; 251(4998): 1231 - 1233.
[Abstract] [PDF]


Home page
J Biol ChemHome page
P. S. Brignola, K. Lackey, S. H. Kadwell, C. Hoffman, E. Horne, H. L. Carter, J. D. Stuart, K. Blackburn, M. B. Moyer, K. J. Alligood, et al.
Comparison of the Biochemical and Kinetic Properties of the Type 1 Receptor Tyrosine Kinase Intracellular Domains: DEMONSTRATION OF DIFFERENTIAL SENSITIVITY TO KINASE INHIBITORS
J. Biol. Chem., January 11, 2002; 277(2): 1576 - 1585.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1990 by the American Association of Cancer Research.